Gilead Sciences
GILD
#129
Rank
ยฃ112.83 B
Marketcap
ยฃ90.94
Share price
-1.14%
Change (1 day)
27.06%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ27.81 Billion

According to Gilead Sciences's latest financial reports the company's total liabilities are ยฃ27.81 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ31.67 B2.48%
2023-12-31ยฃ30.90 B-10.89%
2022-12-31ยฃ34.68 B-0.15%
2021-12-31ยฃ34.73 B-5.66%
2020-12-31ยฃ36.81 B23.87%
2019-12-31ยฃ29.72 B-10.47%
2018-12-31ยฃ33.19 B-9.87%
2017-12-31ยฃ36.83 B20.83%
2016-12-31ยฃ30.48 B38.56%
2015-12-31ยฃ22.00 B81.76%
2014-12-31ยฃ12.10 B84.29%
2013-12-31ยฃ6.56 B-9.24%
2012-12-31ยฃ7.23 B7.78%
2011-12-31ยฃ6.71 B89.46%
2010-12-31ยฃ3.54 B79.58%
2009-12-31ยฃ1.97 B17.04%
2008-12-31ยฃ1.68 B49.91%
2007-12-31ยฃ1.12 B-0.64%
2006-12-31ยฃ1.13 B164.3%
2005-12-31ยฃ0.42 B188.4%
2004-12-31ยฃ0.14 B-51.85%
2003-12-31ยฃ0.30 B-31.01%
2002-12-31ยฃ0.44 B89.34%
2001-12-31ยฃ0.23 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
ยฃ60.40 B 117.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ5.65 B-79.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ102.39 B 268.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ2.84 B-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ8.25 B-70.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.74 B 211.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.17 B 206.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ68.32 B 145.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ58.24 B 109.40%๐Ÿ‡บ๐Ÿ‡ธ USA